| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.29 | 1e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |